Although higher IL-6 levels are reportedly associated with worse OS and PFS in patients with melanoma and non-small-cell lung carcinoma undergoing ICI (Keegan et al., 2020; Laino et al., 2020), reports on patients with UC are lacking. This evidence concerns the gene IL6 and non-small cell lung carcinoma.